Simoens, S
Huys, I
Article History
Received: 7 March 2017
Revised: 13 July 2017
Accepted: 14 July 2017
First Online: 7 September 2017
Competing interests
: SS and IH are the founders of the KU Leuven Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL), in which Biogen participates. The authors declare no conflict of interest.